Form 4: IDEAYA Biosciences Director Acquires Stock Options

IDEAYA Biosciences reports that Director Jeffrey Stein acquired 20,000 stock options.

Summary

• Director Jeffrey Stein acquired 20,000 stock options in IDEAYA Biosciences, Inc. on June 16, 2026.
• The options have an exercise price of $30.57 and an expiration date of June 16, 2036.
• These options are subject to vesting conditions, with full vesting occurring on the first anniversary of the grant date or immediately prior to the next Annual Meeting, provided the reporting person remains in service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard executive compensation action rather than a significant financial event.

Positives

• Director's acquisition of stock options signals confidence in the company's future prospects.
• The grant of 20,000 options indicates a significant incentive for the director's continued service and performance.

Future Outlook

The vesting schedule for the stock options suggests a forward-looking commitment from the director, tied to continued service and company performance over the next year and beyond.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aligning executive incentives with shareholder value and long-term company growth.

Stakeholder Impact

• Shareholders: The issuance of options to a director can be viewed positively as it aligns management's interests with those of shareholders, potentially driving future stock performance.
• Employees: This action is typical within corporate governance and may not have a direct, immediate impact on other employees.

Next Steps

• The director's stock options will vest according to the specified schedule.
• Continued service by the reporting person through the vesting dates is required for full vesting.

Key Dates

Keywords

IDEAYA Biosciences, IDYA, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act